Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (441-450 of 476) with videos related to

Pageof 48
Sort By:
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Cancer Discovery|December 19, 2013
Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemiaRongqing Pan, Leah J Hogdal, Juliana M Benito, et al.
Blood|January 19, 2012
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLZejuan Li, Hao Huang, Yuanyuan Li, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative studyZejuan Li, Tobias Herold, Chunjiang He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Nature Cancer|June 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimeticsXin He, Lei Zhang, Yang Li, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Leukemia|March 3, 2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trialRichard A Larson, Sumithra J Mandrekar, Lucas J Huebner, et al.
Pageof 48

Showing results (441-450 of 476) with videos related to

Sort By:
Pageof 48
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Cancer Discovery|December 19, 2013
Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemiaRongqing Pan, Leah J Hogdal, Juliana M Benito, et al.
Blood|January 19, 2012
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AMLZejuan Li, Hao Huang, Yuanyuan Li, et al.
British Journal of Haematology|September 22, 2025
Allogeneic haematopoietic cell transplantation in advanced systemic mastocytosis in the new era: A CIBMTR studyCelalettin Ustun, Mei-Jie Zhang, Andrew Peterson, et al.
Nature Communications|September 1, 2023
Acquired miR-142 deficit in leukemic stem cells suffices to drive chronic myeloid leukemia into blast crisisBin Zhang, Dandan Zhao, Fang Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2013
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative studyZejuan Li, Tobias Herold, Chunjiang He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2014
Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene scoreGuido Marcucci, Pearlly Yan, Kati Maharry, et al.
Nature Cancer|June 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimeticsXin He, Lei Zhang, Yang Li, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Leukemia|March 3, 2021
Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trialRichard A Larson, Sumithra J Mandrekar, Lucas J Huebner, et al.
Pageof 48